Antonio T. Orgaz-Cano
Mataro, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.
Journal: Therapeutic advances in neurological disorders
Published: January 14, 2026
Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study.
Journal: Clinical drug investigation
Published: September 17, 2024
Gadolinium-enhanced brain lesions in multiple sclerosis relapse.
Journal: Neurologia
Published: August 10, 2021
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial.
Journal: European journal of neurology
Published: July 08, 2018
Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.
Journal: Brain : a journal of neurology
Published: December 18, 2017
Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients.
Journal: Cytometry. Part B, Clinical cytometry
Published: December 13, 2016
Fatigue Improvement after Switching Multiple Sclerosis Treatment from Interferon-β to Glatiramer Acetate in Clinical Practice.
Journal: European neurology
Published: March 30, 2016
The Mataró Stroke Registry: a 10-year registry in a community hospital.
Journal: Neurologia (Barcelona, Spain)
Published: August 24, 2013
Rapid assessment of transient ischaemic attack in a hospital with no on-call neurologist.
Journal: Neurologia (Barcelona, Spain)
Published: February 05, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026